🔗 Share this article

An underground economy for unlicensed slimming medications is being driven by social media fitness personalities and vendors on messaging platforms, according to recent findings.

Investigational Drug Acquiring Popularity Via Social Media

The experimental drug, which is still in research studies, is being promoted by online personalities for its supposed weight-reducing effects. Viewers are urged to contact these accounts privately for source information, while also receiving discount codes.

Thriving Trade on Social Networks

Separately, a flourishing trade exists on messaging services, where groups with thousands of participants share comparison images, administration instructions and assertions of next-day UK delivery. Vendors promote the substance there before directing buyers to WhatsApp for purchases.

Learning About Retatrutide

Retatrutide is an investigational injection created by American pharmaceutical company Eli Lilly. The treatment affects three gut hormones – glucagon-like peptide-1, GIP and glucagon. Preliminary studies indicate it could help individuals reduce up to 25% of their total weight. Referred to as the “triple G”, the drug is being promoted online as the successor to Ozempic.

Medical Professionals Voice Concerns

However, doctors and pharmacists have warned that the distribution of what remains an unapproved drug in the UK is worrisome and could lead to users injecting products of unknown origin.

Several professionals stated the demand for the experimental drug could be connected to the increasing cost of licensed slimming treatments such as Mounjaro.

Legal Position and Enforcement

Marketing retatrutide on social media or Telegram is prohibited in the UK, as it is an unapproved drug that must not be promoted or distributed for human use under the Human Medicines Regulations 2012.

Several content creators try to circumvent the regulations by referring to the substance as a “research chemical” or describing it as “not for human consumption”. The substance is not a controlled substance, but promotion and distribution can still violate medicines, advertising, and customer regulations, potentially leading to penalties, legal action or prison.

Platform Response and Material Elimination

According to TikTok, the service has removed problematic material and banned related hashtags and search suggestions. The company stated it was committed to maintaining the platform secure and investing in strengthening enforcement strategies.

Online Marketplace Operations

Investigations also discovered communities with up to 9,000 participants marketing the experimental drug using Telegram's integrated discovery tool, which operates like a public directory. Entering “retatrutide” immediately displays channels with numerous of users, filled with photos of slimming results, glowing reviews and detailed instructions for mixing or administering at residence.

Within moments of joining one community, a seller shared contact information, where most purchases occur. The vendor provided an guidebook and promised delivery within 48 hours. When asked whether the product was genuine, one seller said: “You can’t be sure.” Another provided a image of a alleged laboratory certificate. Not one asked about body mass, health issues or past usage.

Item Information and Costs

Within these groups, posts display black plastic parcels with Royal Mail labels, stating to contain new batches. One message read: “It took eight of us to load them this morning.”

Customers can select between powder vials, mixed at residence with purified liquid, or pre-filled pens typically priced at 160 pounds for 20mg. When asked how much time a injector should last, vendors give conflicting responses ranging from a few weeks to “depends on your body”.

Service Oversight and Safety Actions

A spokesperson for the messaging service stated it actively moderated dangerous material on its platform including material that promoted the “misuse of controlled medications”. The organization added that it removed “millions of pieces of harmful content each day”.

Healthcare Professional Cautions

“People are administering materials they cannot confirm. Even if the science behind this drug is sound, these digital versions may not contain what they advertise,” said Jason Murphy, the director of pharmacy at Chemist4U.

A medical professional of Asda Online Doctor linked the increase in demand to recent price rises for approved weight-loss drugs such as Mounjaro. “With prices increasing, individuals are turning to online platforms. But counterfeit injections are highly risky. You cannot know what’s inside or whether the environment they were made in was clean,” she said.

Her team has previously seen patients injured by personal administration from unverified suppliers. “We understand the frustration, but purchasing from messaging apps or communication platforms is gambling with your health,” stated the doctor. “These materials could be contaminated or improperly measured.”

Manufacturer Statement

A spokesperson from the pharmaceutical company said retatrutide was in phase 3 clinical trials and had not been reviewed or approved by any regulatory agency globally. “Consequently at this time no one can sell [it] for human use,” they said, noting that any item “falsely representing itself as a company investigational product not yet approved … may expose patients to potentially serious health risks”.